Involvement of CD8+ cells in protective mechanisms in canine mammary adenocarcinomas (short communication)

Bulletin of the Veterinary Institute in Pulawy

Volumn 51, Issue 3, 2007, Pages 445-448

  Nowak, Margin ^a   Madej, Jan P ^b   Rossowska, Joanna ^c   Madej, Janusz A ^a  

^a Laboratory of Cellular Interactions   (Poland)

^b WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Adenocarcinoma; Bitch; CD8+; Mammary gland

Indexed keywords

CANIDAE;

EID: 38049158102     PISSN: 00424870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Baxevanis C.N., Dedoussis G.V., Papadopoulos N.G., Missitzis I., Stathopoulos G.P., Papamichail M.: Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 1994, 74, 1275-1282.
2. Bilik R., Mor C., Hazaz B., Moroz C.: Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer. Cancer Immunol Immunother 1989, 28, 143-147.
3. Chin Y., Janseens J., Vandepitte J., Vandenbrande J., Opdebeek L., Raus J.: Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 1992, 12, 1463-1466.
4. Gołab J., Jakóbisiak M., Lasek W.: Immunology. PWN, Warszawa, 2002.
5. Kruś S., Skrzypek-Fakhoury E.: Clinical Pathomorphology. PZWL, Warszawa, 1996.
6. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Palucka K., Banchereau J.: Interleukin IL-15 skews monocyte differentation into dendritic cells with features of Langerhans cells. J Exp Med 2001, 194, 1013-1020.
7. Roitt I., Brostoff J., Male D.: Immunology. PZWL, Warszawa, Ed. Slowiński Verlag, Brema, 2000.
8. Sheu B.C., Hsu S.M., Ho H.N., Lin R.H., Torng P.L., Huang S.C.: Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 1999, 86, 1537-1543.
9. Snyderman C.H., Heo D.S., Chen K., Whiteside T.L., Johnson J.T.: T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer. Head Neck 1989, 11, 331-336.